Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 279

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Activating Macrophage‐Mediated Cancer Immunotherapy by Genetically Edited Nanoparticles

Open access
Rao, Lang, Zhao, Shu‐Kun, Wen, Churan, Tian, Rui, Lin, Lisen, Cai, Bo, Sun, Yue, Kang, Fei, Yang, Zhen, He, Liangcan, Mu, Jing, Meng, Qian‐Fang, Yao, Guangyu, Xie, Ni, Chen, Xiaoyuan·2020·Advanced Materials

Abstract

Immunomodulation of macrophages against cancer has emerged as an encouraging therapeutic strategy. However, there exist two major challenges in effectively activating macrophages for antitumor immunotherapy. First, ligation of signal regulatory protein alpha (SIRPα) on macrophages to CD47, a “don't eat me” signal on cancer cells, prevents macrophage phagocytosis of cancer cells. Second, colony stimulating factors, secreted by cancer cells, polarize tumor‐associated macrophages (TAMs) to a tumorigenic M2 phenotype. Here, it is reported that genetically engineered cell‐membrane‐coated magnetic nanoparticles (gCM‐MNs) can disable both mechanisms. The gCM shell genetically overexpressing SIRPα variants with remarkable affinity efficiently blocks the CD47‐SIRPα pathway while the MN core promotes M2 TAM repolarization, synergistically triggering potent macrophage immune responses. Moreover, the gCM shell protects the MNs from immune clearance; and in turn, the MN core delivers the gCMs into tumor tissues under magnetic navigation, effectively promoting their systemic circulation and tumor accumulation. In melanoma and breast cancer models, it is shown that gCM‐MNs significantly prolong overall mouse survival by controlling both local tumor growth and distant tumor metastasis. The combination of cell‐membrane‐coating nanotechnology and genetic editing technique offers a safe and robust strategy in activating the body's immune responses for cancer immunotherapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/adma.202004853

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Cited by

See all 279

Metadata

Authors
Rao, L., Zhao, S., Wen, C., Tian, R., Lin, L., Cai, B., Sun, Y., Kang, F., Yang, Z., He, L., Mu, J., Meng, Q., Yao, G., Xie, N., & Chen, X.
Venue
Advanced Materials
Publisher
Wiley
Published
2020-10-21
Volume
32
Issue
47
Pages
e2004853-e2004853
ISSN
  • 0935-9648 (ISSN-L)
  • 1521-4095
OpenAlex
W3094037746
Cited by
279
References
49
FWCI
9.83
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Activating Macrophage‐Mediated Cancer Immunotherapy by Genetically Edited Nanoparticles. https://app.cochat.ai/papers/10.1002/adma.202004853
The paper
Rao, L., Zhao, S., Wen, C., Tian, R., Lin, L., Cai, B., Sun, Y., Kang, F., Yang, Z., He, L., Mu, J., Meng, Q., Yao, G., Xie, N., & Chen, X. (2020). Activating Macrophage‐Mediated Cancer Immunotherapy by Genetically Edited Nanoparticles. Advanced Materials. https://doi.org/10.1002/adma.202004853

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.